| |
| |
|
| Insider
Information: |
Selick Harold E |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
734,926 |
|
|
Indirect Shares
|
36,129 |
|
|
| Direct
Value |
$1,754,432 |
|
|
|
Indirect Value
|
$20,208 |
|
|
| Total
Shares |
771,055 |
|
|
| Total
Value |
$1,774,639 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 229.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Molecular Templates, Inc. |
MTEM |
Chief Executive Office... |
2014-10-02 |
433,870 |
2011-08-09 |
19,515 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2018-06-08 |
256,828 |
2009-08-03 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director |
2015-08-20 |
16,232 |
2015-08-20 |
16,614 |
Premium* |
|
|
Protagonist Therapeutics, Inc |
PTGX |
Director |
2024-03-07 |
27,996 |
2019-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTGX |
Protagonist Therapeutics,... |
Director |
– • – |
2024-03-07 |
4 |
OE |
$1.89 |
$12,266 |
D/D |
6,490 |
27,996 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • – |
2023-04-10 |
4 |
OE |
$0.87 |
$5,391 |
D/D |
6,196 |
21,506 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • – |
2020-03-12 |
4 |
B |
$6.70 |
$80,400 |
D/D |
12,000 |
15,310 |
2.39 |
% |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • – |
2019-04-01 |
4 |
OE |
$1.31 |
$4,336 |
D/D |
3,310 |
3,310 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2018-06-08 |
4 |
A |
$2.76 |
$150,000 |
D/D |
54,348 |
256,828 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2017-06-09 |
4 |
A |
$2.47 |
$150,001 |
D/D |
60,729 |
202,480 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2016-06-02 |
4 |
A |
$3.52 |
$250,001 |
D/D |
71,023 |
141,751 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,232 |
16,232 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
382 |
16,614 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2015-05-28 |
4 |
A |
$6.80 |
$150,001 |
D/D |
22,059 |
70,728 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2014-11-26 |
4 |
B |
$8.08 |
$48,487 |
D/D |
6,000 |
48,669 |
2.39 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2014-10-02 |
4 |
OE |
$2.05 |
$42,931 |
D/D |
20,942 |
433,870 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2014-05-28 |
4 |
A |
$9.31 |
$50,004 |
D/D |
5,371 |
42,669 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2013-06-17 |
4 |
OE |
$1.86 |
$36,469 |
D/D |
19,607 |
403,928 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2013-05-21 |
4 |
A |
$8.37 |
$50,002 |
D/D |
5,974 |
37,298 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2012-06-05 |
4 |
A |
$6.31 |
$50,000 |
D/D |
7,924 |
31,324 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2011-08-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
18,000 |
19,515 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2011-08-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,000 |
336,321 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2011-06-22 |
4 |
A |
$5.89 |
$50,000 |
D/D |
8,489 |
23,400 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2011-03-11 |
4 |
B |
$2.10 |
$100,000 |
D/D |
47,619 |
372,321 |
2.81 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2010-06-09 |
4 |
A |
$5.05 |
$49,995 |
D/D |
9,900 |
14,911 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2009-10-05 |
4 |
B |
$1.86 |
$97,382 |
D/D |
52,356 |
312,670 |
2.81 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-08-03 |
4 |
A |
$8.42 |
$42,193 |
D/D |
5,011 |
5,011 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2009-06-05 |
4 |
B |
$1.48 |
$14,800 |
D/D |
10,000 |
259,897 |
2.81 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Chief Executive Officer |
• • – |
2009-06-03 |
4 |
B |
$1.55 |
$15,500 |
D/D |
10,000 |
249,897 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
